Drug Profile
BY 758
Latest Information Update: 02 Apr 2008
Price :
$50
*
At a glance
- Originator Nycomed
- Class
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastro-oesophageal reflux; Heartburn
Most Recent Events
- 02 Apr 2008 Discontinued - Preclinical for Gastro-oesophageal reflux in Germany (PO)
- 02 Apr 2008 Discontinued - Preclinical for Heartburn in Germany (PO)
- 09 Jul 2002 Byk Gulden is now called Altana Pharma